<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01263964</url>
  </required_header>
  <id_info>
    <org_study_id>EA4/118/10</org_study_id>
    <secondary_id>01 EO 0801</secondary_id>
    <nct_id>NCT01263964</nct_id>
  </id_info>
  <brief_title>Troponin Elevation in Acute Ischemic Stroke (TRELAS)</brief_title>
  <acronym>TRELAS</acronym>
  <official_title>Troponin Elevation in Acute Ischemic Stroke (TRELAS) - a Prospective Study on the Frequency and Correlation to Coronary Artery Disease and to Stroke Localisation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in&#xD;
      Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in&#xD;
      acute ischemic stroke. Consecutive patients with acute ischemic stroke admitted to the&#xD;
      Department of Neurology Campus Benjamin Franklin of the university hospital Charité will be&#xD;
      screened for cTnT elevations suggestive of myocardial infarction (&gt;0,05 µg/l). Patients with&#xD;
      increased troponin will undergo diagnostic coronary angiography within 72 hours. Diagnostic&#xD;
      findings of coronary angiographies taken out in age- and gender-matched patients presenting&#xD;
      with NSTE-ACS (Non-ST-Elevation Acute Coronary Syndrome) to the Division of Cardiology will&#xD;
      serve as a control. The primary endpoint of the study will be the occurrence of culprit&#xD;
      lesions indicating focal cardiac damage on the basis of an acute CAD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the prospective observational trial TRELAS (TRoponin ELevation in&#xD;
      Acute ischemic Stroke) is to elucidate the underlying pathomechanism of cTnT elevation in&#xD;
      acute ischemic stroke in order to give guidance for clinical practise. All consecutive&#xD;
      patients with acute MRI- or CT-confirmed ischemic stroke admitting within 72 hours after&#xD;
      symptom onset to the Department of Neurology Campus Benjamin Franklin of the university&#xD;
      hospital of the Charité will be screened for cTnT elevations suggestive of myocardial&#xD;
      infarction (&gt;0,05 µg/l) on admission and day 2. Patients with increased troponin will undergo&#xD;
      diagnostic coronary angiography within 72 hours. Diagnostic findings of coronary&#xD;
      angiographies taken out in age- and gender-matched patients presenting with NSTE-ACS&#xD;
      (Non-ST-Elevation Acute Coronary Syndrome) to the Division of Cardiology will serve as a&#xD;
      control. The primary endpoint of the study will be the occurrence of angiographic culprit&#xD;
      lesions indicating focal cardiac damage on the basis of an acute CAD. Secondary endpoints&#xD;
      will be the localisation of stroke in the cerebral imaging and ventriculographic findings of&#xD;
      wall motion abnormalities suggestive of neurally mediated global cardiac dysfunction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>culprit lesion on coronary angiogram</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>transient apical ballooning on levocardiogram</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke localization</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">58</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>stroke, troponin elevation</arm_group_label>
    <description>Patients with stroke (proven by cerebral imaging) and troponin elevation undergoing coronary angiogram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-stemi (controll group)</arm_group_label>
    <description>Patients with troponin elevation suggesting non-stemi undergoing coronary angiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>coronary angiogram</intervention_name>
    <description>coronary angiogram</description>
    <arm_group_label>non-stemi (controll group)</arm_group_label>
    <arm_group_label>stroke, troponin elevation</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biomarkers indicating myocardial or neuronal damage&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted because acute ischemic stroke and additional troponin-elevation(cases) or&#xD;
        non-stemi (controlls)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Acute ischemic stroke, confirmed by cerebral MRI or CT, respectively&#xD;
&#xD;
          2. Inclusion within ≤ 72 hours after symptom onset&#xD;
&#xD;
          3. hsTroponin T &gt;0,05 µg/l&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Renal insufficiency (creatinine ≥1,2 mg/dl)&#xD;
&#xD;
          2. Limited life expectancy or mRS ≥ 4 prior to stroke event leading to hospital admission&#xD;
&#xD;
          3. Contraindications for the coronary angiography&#xD;
&#xD;
          4. Age &lt; 18 years&#xD;
&#xD;
          5. Pregnancy&#xD;
&#xD;
          6. Patient unwilling or unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Endres, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Charite Universitätsmedizin-Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charite Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>December 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2010</study_first_posted>
  <last_update_submitted>July 18, 2014</last_update_submitted>
  <last_update_submitted_qc>July 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Christian Nolte</investigator_full_name>
    <investigator_title>PD Dr.med.</investigator_title>
  </responsible_party>
  <keyword>ischemic stroke</keyword>
  <keyword>troponin elevation</keyword>
  <keyword>transient apical ballooning</keyword>
  <keyword>acute coronary syndrome</keyword>
  <keyword>troponin elevation,</keyword>
  <keyword>culprit lesion on coronary angiogram,</keyword>
  <keyword>troponin elevation and stroke localisation (temporal lobe?)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

